首页> 外文期刊>BMC Public Health >Interventions to reduce post-acute consequences of diarrheal disease in children: a systematic review
【24h】

Interventions to reduce post-acute consequences of diarrheal disease in children: a systematic review

机译:减少儿童腹泻病急性后后果的干预措施:系统评价

获取原文
           

摘要

Although acute diarrhea often leads to acute dehydration and electrolyte imbalance, children with diarrhea also suffer long term morbidity, including recurrent or prolonged diarrhea, loss of weight, and linear growth faltering. They are also?at increased risk of post-acute mortality. The objective of this systematic review was to identify interventions that address these longer term consequences of diarrhea. We searched Medline for randomized controlled trials (RCTs) of interventions conducted in low- and middle-income countries,?published between 1980 and 2016 that included children under 15?years of age with diarrhea and follow-up of at least 7?days. Effect measures were summarized by intervention. PRISMA guidelines were followed. Among 314 otherwise eligible RCTs, 65% were excluded because follow-up did not extend beyond 7?days. Forty-six trials were included, the majority of which (59%) were conducted in Southeast Asia (41% in Bangladesh alone). Most studies were small, 76% included less than 200 participants. Interventions included: therapeutic zinc alone (28.3%) or in combination with vitamin A (4.3%), high protein diets (19.6%), probiotics (10.9%), lactose free diets (10.9%), oral rehydration solution (ORS) formulations (8.7%), dietary supplements (6.5%), other dietary interventions (6.5%), and antimicrobials (4.3%). Prolonged or recurrent diarrhea was the most commonly reported outcome, and was assessed in ORS, probiotic, vitamin A, and zinc trials with?no consistent benefit observed. Seven trials evaluated mortality, with follow-up times ranging from 8?days to 2?years. Only a single trial found a mortality benefit (therapeutic zinc). There were mixed results for dietary interventions affecting growth and diarrhea outcomes in the post-acute period. Despite the significant post-acute mortality and morbidity associated with diarrheal episodes, there is sparse evidence evaluating the effects of interventions to decrease these sequelae. Adequately powered trials with extended follow-up are needed to identify effective interventions to prevent post-acute diarrhea outcomes.
机译:尽管急性腹泻通常会导致急性脱水和电解质失衡,但腹泻儿童还患有长期发病,包括反复发作或长期腹泻,体重减轻和线性生长步履蹒跚。它们还增加了急性后死亡的风险。该系统评价的目的是确定应对腹泻这些长期后果的干预措施。我们在Medline中搜索了在中低收入国家/地区进行的干预措施的随机对照试验(RCT),该研究发表于1980年至2016年之间,其中包括15岁以下腹泻的儿童,至少随访7天。干预措施总结了疗效措施。遵循PRISMA指南。在314例符合条件的RCT中,由于随访没有超过7天,因此排除了65%。包括四十六项试验,其中大多数(59%)在东南亚进行(仅孟加拉国为41%)。大多数研究规模较小,有76%的研究对象少于200名。干预措施包括:单独使用治疗性锌(28.3%)或与维生素A组合(4.3%),高蛋白饮食(19.6%),益生菌(10.9%),无乳糖饮食(10.9%),口服补液(ORS)配方(8.7%),膳食补充剂(6.5%),其他饮食干预(6.5%)和抗菌剂(4.3%)。长期或反复腹泻是最常报告的结局,并且在ORS,益生菌,维生素A和锌试验中进行了评估,但未观察到一致的益处。七项试验评估了死亡率,随访时间为8天至2年。只有一项试验发现了死亡益处(治疗性锌)。在急性期之后,饮食干预会影响生长和腹泻结果,结果好坏参半。尽管与腹泻相关的急性后死亡率和发病率显着,但仍缺乏评估干预措施减少这些后遗症效果的证据。需要有足够的试验和扩展的随访来确定有效的干预措施,以防止急性腹泻后的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号